Targeted Chemotherapy with Personalized Immunotherapy

Targeted Chemotherapy with Personalized Immunotherapy: An AI Approach is an essential guide for healthcare teams, offering groundbreaking insights into novel immunotherapies and personalized treatments to improve cancer patient care and quality of life. In the last 20 years, there have been significant leaps forward in the treatment of cancer. We now have a far better understanding of how our cells interact with one another, how cancer suppresses and hides from the immune system, and how to support the body in reacting to stop the spread of cancer. Nevertheless, there is still a great deal more to learn in this field. Researchers are working to develop methods that will help pinpoint the most effective treatment for patients. Through this research, they have discovered that, for certain patients, the best results may be reached by combining precisely targeted chemotherapy with personalized immunotherapy. Instead of treating patients with medications that are detrimental to the body as a whole, researchers now aim to identify the molecules that play an essential part in the communication that takes place between cells. This study will help pave the way for the development of novel immunotherapies that will help the body in its fight against cancer. In order to accurately plan cancer treatment, participation from a number of different members of the healthcare team is essential. This book is a comprehensive guide for all members of this team, providing insights into groundbreaking new treatments to cure more patients and improve quality of life.

Foreword xxi Preface xxiii 1 Assessing Predictive Accuracy: Model Validation in Cancer Diagnostics 1 M. Sudha, Arun Elias, G. Gurumoorthy, S. Rajalakshmi and S. K. Muthusundar 1.1 Introduction 2 1.1.1 Conventional Cancer Diagnosis 3 1.1.2 Machine Learning in Cancer Diagnosis 3 1.1.3 Types of Cancer in Focus 4 1.1.3.1 Breast Cancer 4 1.1.3.2 Lung Cancer 4 1.1.3.3 Skin Cancer 4 1.1.4 Objectives of Study 4 1.1.5 Study Scope 5 1.1.6 Performance Metrics 6 1.1.7 Limitations and Future Directions 6 1.2 Literature Review 7 1.3 Methodology 9 1.3.1 Data Acquisition 9 1.3.2 Data Preprocessing 10 1.3.2.1 Dealing with Missing Data 10 1.3.2.2 Normalization and Standardization 10 1.3.2.3 Feature Selection and Dimensionality Reduction 11 1.3.3 Machine Learning Models 11 1.3.3.1 Support Vector Machine (SVM) 11 1.3.3.2 Random Forest (RF) 12 1.3.3.3 k-Nearest Neighbors (k-NN) 12 1.3.3.4 Logistic Regression (LR) 12 1.3.3.5 Hyperparameter Tuning 13 1.3.4 Performance Metrics 13 1.4 Analysis of Results 14 1.4.1 The Overall Performance of Each Model on the Breast Cancer Dataset 14 1.4.2 Models’ Performance for Lung Cancer Dataset 16 1.4.3 Model Performance on Skin Cancer Dataset 17 1.4.4 Analysis of Inter-Cancer Type Performance Comparison 18 1.5 Discussion of Results 19 1.6 Conclusion 20 References 21 2 Applying Transfer Learning to Accelerate Cancer Classification and Prediction 23 T. Ravi, Shashidhar Gurav, Nandhini, Vijayaraj and S. K. Muthusundar 2.1 Introduction 24 2.1.1 Background on Cancer Classification 24 2.1.2 Transfer Learning in Medical Imaging 25 2.1.3 Model Development 26 2.2 Literature Review 27 2.2.1 Application of Transfer Learning in Breast Cancer Diagnosis 27 2.3 Methodology 30 2.3.1 Introduction 30 2.3.2 Data Preparation 31 2.3.2.1 Data Source 31 2.3.2.2 Data Collection 31 2.3.2.3 Data Preprocessing 31 2.3.2.4 Normalization 31 2.3.2.5 Handling Missing Values 32 2.3.2.6 Feature Selection 32 2.3.2.7 Data Partitioning 32 2.3.3 Model Design 33 2.3.3.1 Transfer Learning Approach 33 2.3.4 Implementation Tools 35 2.4 Results 36 2.4.1 Data Distribution 36 2.4.2 Accuracy, Precision, Recall, and F1-Score 37 2.4.3 Confusion Matrix 37 2.4.4 ROC Curve Analysis 39 2.4.5 Comparison on Traditional Machine Learning Models 39 2.5 Discussion of Results 40 2.5.1 Model Strengths 40 2.5.2 Areas for Improvement 40 2.6 Conclusion 41 References 43 3 Artificial Intelligence in Cancer Screening: Innovations in Early Detection 45 Arun Elias, V. Vaithianathan, S.K. Rajesh Kanna, G.M. Raja and S.K. Muthusundar 3.1 Introduction 46 3.1.1 Background on Cancer Screening 46 3.1.2 Role of Artificial Intelligence 47 3.1.3 Research Methodology 47 3.1.4 AI in Medical Imaging 48 3.1.5 Challenges and Ethical Considerations 48 3.2 Literature Review 50 3.3 Methodology 53 3.3.1 Dataset Collection 53 3.3.2 Data Preprocessing 54 3.3.3 Architecture Model Design 55 3.3.4 Training and Validation 56 3.3.5 Metrics to Measure 57 3.4 Results 58 3.4.1 Model Performance Metrics 58 3.4.2 Confusion Matrix Analysis 59 3.4.3 Receiver Operating Characteristic Curve 60 3.4.4 Comparison with Existing Models 61 3.4.5 Error Analysis 62 3.5 Future Directions 62 3.6 Conclusion 63 References 64 4 Comprehensive Approaches to Survival Analysis and Prognostic Modeling in Cancer Research: Integrating Statistical Techniques, and Clinical Variables 67 B. Sriman, J. Maria Arockia Dass, R. Seetha and Ashish Kumar 4.1 Introduction 68 4.1.1 Objectives 70 4.2 Literature Review 71 4.3 Methodology 74 4.3.1 Collection and Preprocessing 75 4.3.2 Cox Proportional Hazards Model 76 4.3.3 Random Survival Forest (RSF) 76 4.3.4 DeepSurv: Neural Network-Based Survival Model 77 4.3.5 Model Evaluation and Comparison 78 4.4 Results 79 4.4.1 General Comparison of Ability 79 4.4.2 Results of Cox Proportional Hazards (CPH) Model 79 4.4.3 RSF Results 82 4.4.4 Results on DeepSurv 82 4.4.5 Model Comparison and Discussion 84 4.4.6 Impact on Personalized Medicine 86 4.5 Conclusion 86 References 87 5 Exploring Cancer Therapeutics: A Collection of Case Studies 89 L. Selvam, Annie Silviya S. H., Singaravelan M. and Ira Aditi 5.1 Introduction 90 5.1.1 Conventional Cancer Therapies: Limitations and Challenges 90 5.1.2 The New Era of Targeted Therapies 91 5.1.3 Immunotherapy 91 5.1.4 Case Study: Targeted Therapy in HER2-Positive Breast Cancer 92 5.1.5 Case Study: Immunotherapy in Advanced Melanoma 93 5.2 Literature Review 93 5.3 Methodology 96 5.3.1 Research Design 97 5.3.2 Patient Selection 97 5.3.2.1 Case Study: HER2-Positive Breast Cancer (Trastuzumab) 98 5.3.2.2 Advanced Melanoma Case Study (Pembrolizumab) 98 5.3.3 Treatment Protocols 98 5.3.3.1 Trastuzumab Protocol for HER2-Positive Breast Cancer 99 5.3.4 Data Collection 99 5.3.4.1 Clinical and Imaging Data 100 5.3.4.2 Immune and Genetic Markers 100 5.3.5 Statistical Analysis 100 5.4 Results 101 5.4.1 Tumor Response 101 5.4.2 Survival Analysis 103 5.4.3 Recurrence Rate and Disease Control 105 5.4.4 Immune-Related Adverse Events and Safety Profile 106 5.5 Conclusion 109 References 109 6 Predicting Cancer Outcomes Using Transfer Learning: Harnessing Pre-Trained Models and Cross-Domain Knowledge for Enhanced Prognosis and Personalized Treatment Strategies 111 R. Ramachandran, V. Vaissnave, Vijayaraj and S. K. Muthusundar 6.1 Introduction 112 6.1.1 Background 112 6.1.2 Objectives 113 6.2 Literature Review 114 6.3 Methodology 119 6.3.1 Data Collection 119 6.3.2 Preprocessing the Data 120 6.3.3 Modeling 121 6.3.4 Model Assessment 122 6.3.5 Implementation of the Integrated Model 122 6.4 Results 123 6.4.1 Model Performance Metrics 123 6.4.2 Baseline Model Comparisons 125 6.4.3 Feature Importance Analysis 125 6.4.4 Clinical Validation Results 127 6.5 Conclusion 128 References 129 7 Predicting Cancer Outcomes with RNNs: A Time Series Approach 133 M. Mahalakshmi, Annie Silviya S. H., Kumud Sachdeva and Rajan Sachdeva 7.1 Introduction 134 7.1.1 Background 134 7.1.2 Significance of Ensemble Learning 134 7.1.3 Objectives 135 7.1.4 Significance of the Study 136 7.2 Literature Review 136 7.3 Methodology 137 7.3.1 Objective 137 7.3.2 Data Collection 137 7.3.2.1 Dataset 137 7.3.3 Preprocessing 138 7.3.3.1 Data Drawing 138 7.3.3.2 Normalization Numerical Features 138 7.3.3.3 Point Selection 139 7.3.4 Feature Selection 139 7.3.5 Ensemble Learning Techniques 140 7.3.6 Model Evaluation Metrics 142 7.3.7 Cross-Validation 143 7.4 Results 143 7.4.1 Model Performance 143 7.5 Results 149 7.5.1 Cross-Validation Results 149 7.5.2 Model Comparison 149 7.6 Conclusion 151 References 151 8 AI in Cancer Screening and Early Detection 153 Priya Batta and Soumen Sardar 8.1 Introduction 153 8.2 Literature Review 157 8.3 Methodology 160 8.4 Results 162 8.5 Conclusion and Future Scope 163 References 164 9 Challenges and Limitations of AI in Oncology 167 Priya Batta 9.1 Introduction 167 9.2 Literature Review 170 9.3 Methodology 172 9.4 Results 174 9.5 Conclusion and Future Scope 174 References 175 10 Predictive Models for Cancer-Related Lymphedema: Enhancing Telerehabilitation and Physiotherapy Management 177 Madhusmita Jena, Charu Chhabra, Huma Parveen, Sahar Zaidi, Noor Fatima and Habiba Sundus 10.1 Introduction 178 10.1.1 Prevalence of Lymphedema 179 10.1.2 Diagnostic Technique for Lymphedema 180 10.1.3 Commonly Used Scales for Diagnosis of Lymphedema 181 10.2 Lymphedema’s Impact on Cancer Survivors 181 10.3 Current Challenges in Lymphedema Management 182 10.4 Role of AI in Lymphedema Management 183 10.4.1 Customizing Physiotherapy Regimens Based on AI Predictions 184 10.4.2 Integrating Telerehabilitation for Effective Lymphedema Management 185 10.5 Conclusion 186 References 186 11 Role of AI in the Prediction of Leukemia and AI-Driven Predictive Models for Rehabilitation Outcomes in Acute Lymphoblastic Leukemia 189 Huma Parveen, Charu Chhabra, Sahar Zaidi, Noor Fatima, Madhusmita Jena and Amaan Ali Khan 11.1 Acute Lymphoblastic Leukemia 190 11.2 Importance of Early Prediction and Rehabilitation in ALL 191 11.3 Role of AI in Healthcare 193 11.4 AI in Leukemia Prediction 194 11.5 AI-Driven Predictive Rehabilitation Outcomes in ALL 196 11.6 Data Privacy and Security in Healthcare Models 199 11.7 Framework for Protecting Data Privacy 200 11.7.1 Acts and Policies 200 11.7.2 National Policies 200 11.7.3 AI Models-Based Privacy Protection 201 11.8 Ethical Concerns in AI Healthcare 202 References 203 12 Data Privacy and Ethical Challenges in AI-Driven Cancer Care 207 Firdaus Jawed, Rabia Aziz, Sumbul Ansari, Shahnawaz Anwar and Sohrab Ahmad Khan 12.1 Introduction to Data Privacy and Ethics in AI-Driven Cancer Care 208 12.2 Types of Sensitive Data in AI-Driven Cancer Care 209 12.3 Ethical Frameworks and Guidelines for Data Privacy 212 12.4 Data Security and Protection Techniques 214 12.5 Bias, Fairness, and Algorithmic Transparency in AI-Driven Cancer Care 216 12.6 Regulatory and Compliance Challenges 219 12.7 Emerging Technologies and Innovations in Privacy 221 12.8 Future Directions in Ethical AI for Cancer Care 222 12.9 Conclusions 224 References 224 13 Cancer Rehabilitation in the Era of Targeted Chemotherapy and Personalized Immunotherapy 229 Rabia Aziz, Firdaus Jawed, Sumbul Ansari, Shahnawaz Anwar and Sohrab Ahmad Khan 13.1 Evolving Landscape of Cancer Treatment 230 13.2 Importance of Cancer Rehabilitation 231 13.3 Integrating Rehabilitation Into AI-Powered Cancer Rehabilitation 232 13.3.1 The Role of Data in Rehabilitation 238 13.3.2 Machine Learning and Predictive Analytics 239 13.3.3 Real-Time Monitoring and Feedback 239 13.3.4 Outcomes Measurement and Continuous Improvement 240 13.3.5 The Rationale for Integration 241 13.3.6 Utilizing Biomarkers in Rehabilitation 241 13.3.7 Multidisciplinary Collaboration 242 13.3.8 Early Intervention Strategies 242 13.3.9 Leveraging Technology for Monitoring and Feedback 243 13.4 Leveraging Data Analytics and AI for Adaptive Rehabilitation 243 13.4.1 The Role of Data Analytics in Rehabilitation 244 13.4.2 AI-Driven Personalization of Rehabilitation Programs 244 13.4.3 Integration of Wearable Technology and Telehealth 245 13.4.4 Virtual Reality (VR) and Augmented Reality (AR) Applications 245 13.5 Tailoring Rehabilitation Strategies for Targeted Therapies 246 13.5.1 Understanding Targeted Therapies and Their Implications 246 13.5.2 Personalized Assessment and Planning 247 13.5.3 Integrating Evidence-Based Interventions 247 13.5.3.1 Physical Therapy 247 13.5.3.2 Occupational Therapy 248 13.5.3.3 Psychosocial Support 249 13.5.3.4 Nutritional Counseling 249 13.5.4 Utilizing Technology for Enhanced Rehabilitation 250 13.6 Future Directions and Emerging Trends 251 13.7 Summary 251 References 252 14 Role of AI in Cancer Screening and Its Detection 257 Muskan, Shweta Sharma, Parul Sharma, Manoj Malik and Jaspreet Kaur 14.1 Introduction 258 14.2 Cancer Mechanisms and Various Pathologies 258 14.3 Conventional Methods of Cancer Screening 260 14.3.1 Mammography 260 14.3.2 Ultrasound 262 14.3.3 Magnetic Resonance Imaging 262 14.3.4 Liquid Biopsies 262 14.3.5 Pap Smear (Papanicolaou Test) 263 14.3.6 Barium X-Ray (Barium Swallow or Enema) 263 14.3.7 Photoacoustic Tomography (PAT) 263 14.3.8 SPECT (Single-Photon Emission Computed Tomography) and PET (Positron Emission Tomography) 263 14.4 Overview of AI (Artificial Intelligence) in Cancer Detection 264 14.5 AI Applications in Cancer Screening Using Deep Learning and Machine Learning 266 14.5.1 AI Models for Breast Cancer 266 14.5.2 AI Models for Lung Cancer 266 14.5.3 AI Models for Skin Cancer 267 14.5.4 AI Models for Gastric Cancers 267 14.5.5 AI Models for Prostate Cancers 269 14.6 Challenges in AI Adoption for Cancer Screening 270 14.7 Proposed Strategies for AI Implementation for Cancer Detection 271 14.8 Conclusion 272 14.9 Future Directions 273 References 274 15 Automated 3D U-Net Framework for Brain Tumor Segmentation and Classification with Insights Into AI-Driven Cancer Research Applications 279 S. Usharani, P. Manju Bala, T. Ananth kumar and G. Glorindal Selvam 15.1 Introduction 280 15.2 Literature Review 283 15.2.1 Brain Tumor MRI Image Segmentation 283 15.2.1.1 Methods for Manual Segmentation 283 15.2.1.2 Methods for Partly-Automated Segmentation 283 15.2.1.3 Methods for Absolutely Automated Segmentation 284 15.2.2 Brain Tumor MRI Classification 285 15.3 Materials and Methods 290 15.3.1 Materials 290 15.3.2 Methods 291 15.3.2.1 System Model 291 15.3.2.2 Multi Scale Feature Extraction Network 293 15.3.2.3 Incremental Feature Improvement 294 15.3.2.4 Loss Function 295 15.4 Experimental Setup 296 15.4.1 Experimental Analysis 296 15.5 Conclusion 301 References 302 16 Early Prediction of Bone Cancer: Integrating Deep Learning Models 309 R. Dhinesh, T. Ananth kumar, P. Kanimozhi and Sunday Adeola Ajagbe 16.1 Introduction 310 16.2 Related Works 311 16.3 Proposed Methodology 313 16.4 Results and Discussion 318 16.5 Conclusion 321 References 322 17 Machine Learning Techniques for Predicting Epileptic Seizures: A Data-Driven Analysis Using EEG Signals 325 Preeti Narooka, Ankit Vishnoi and Jatin Verma 17.1 Introduction 326 17.1.1 Background 326 17.1.2 Objective 326 17.2 Literature Survey 327 17.2.1 Study 1: Feature Extraction Techniques in EEG-Based Seizure Detection 327 17.2.2 Study 2: Application of Deep Learning in Neurological Disorders 327 17.2.3 Study 3: Comparative Analysis of ML Algorithms 328 17.2.4 Study 4: Transfer Learning in EEG Analysis 328 17.2.5 Study 5: Real-Time Seizure Prediction Systems 328 17.2.6 Study 6: Explainable Artificial Intelligence in Seizure Detection 328 17.2.7 Study 7: Challenges in EEG-Based Seizure Detection 329 17.2.8 Study 8: Multimodal Learning Approaches 329 17.3 Methodology 329 17.3.1 Dataset 329 17.3.2 Preprocessing 330 17.3.3 Feature Extraction 330 17.3.4 Model Architecture 331 17.4 Results and Discussion 332 17.4.1 Model Performance 332 17.4.2 Discussion 333 17.4.3 Implications for Healthcare Applications 334 17.5 Conclusion 334 References 334 18 Transfer Learning in Cancer Research 337 Mamta and Nitin 18.1 Definition and Overview of Transfer Learning 338 18.1.1 Transfer Learning Typically Involves the Following Components 338 18.1.2 Importance of Transfer Learning in Cancer Research 339 18.1.3 Challenges in Traditional Cancer Research Approaches 341 18.2 How Transfer Learning Works 344 18.2.1 Types of Transfer Learning 345 18.2.2 Transductive Transfer Learning 346 18.3 Applications of Transfer Learning in Cancer Research 346 18.4 Challenges in Transfer Learning for Cancer 348 18.4.1 Data Scarcity and Domain Adaptation 348 18.4.2 Model Interpretability 349 18.5 Future Directions: Personalized Medicine and Drug Discovery 351 18.5.1 Personalized Medicine: Tailoring Treatment to the Individual 352 18.6 Drug Discovery: Accelerating the Path to New Therapies 353 18.7 Challenges and Ethical Considerations 354 18.8 Conclusion 354 References 355 19 Machine Learning Approaches for Early Detection of Cervical Cancer: A Comparative Study of Classification Models 359 Inam Ul Haq, Janvi Malhotra, Vanshika Rawat, Jyoti Kumari and Gagandeep Kaur 19.1 Introduction 360 19.2 Literature Review of Some Research Papers 364 19.3 Methodology 368 19.4 Results 369 19.5 Conclusion and Future Scope 370 References 370 20 Interactive Data Management for Cancer Care: Leveraging Electronic Health Records and Proteomic Data 375 M. Rohini, S. Oswalt Manoj, J. P. Ananth and D. Surendran 20.1 Introduction 376 20.1.1 Need of Electronic Health Record Maintenance 376 20.1.2 Message Passing Protocol for Cancer EHR Updates 377 20.1.3 Reliable Messaging for Critical Data 379 20.1.4 Microservice-Oriented Cancer Data Staging and Deployment 380 20.2 HER Data Processing 382 20.2.1 Staging Service 382 20.2.1.1 Autoscaling Based on Criticality of EHR System 382 20.2.2 Internal Working of the Staging Service 383 20.2.2.1 Validate and Fetch Dashboard Details 383 20.2.2.2 Execute Stored Procedure 385 20.2.2.3 High-Availability Deployment Phase 386 20.3 Conclusion 388 References 389 21 Artificial Intelligence–Driven Personalized Cancer Treatment 391 Gurwinder Singh, Sarthak Sharma and Aastha Anand 21.1 Introduction: The Dawn of Artificial Intelligence–Powered Cancer Screening 392 21.2 Role of AI in Cancer Screening 395 21.3 Role of AI in Early Detection 399 21.4 Case Studies and Real-World Implementation 401 21.5 Benefits and Opportunities 404 21.6 Conclusion 406 21.7 Future Scope 407 References 408 22 Revolutionizing Breast Cancer Detection: Emerging Trends and Future Technologies 411 Gurmeet Kaur Saini, Inderdeep Kaur and Kanwaldeep Kaur 22.1 Overview 412 22.2 Risk Assessment Types 413 22.3 Risk Elements 413 22.4 Risk Factors for Hormones and Reproduction 413 22.5 Additional Risk Factors 414 22.6 Risk of Breast Cancer Over Time 414 22.6.1 Risk Assessment by Family History 414 22.7 Models for Risk Estimate 415 22.7.1 The Gail Model 415 22.7.2 Claus–Mammary Carcinoma Risk Assessment Model 416 22.7.3 The BRCAPRO Model 418 22.7.4 Tools for Risk Calculation 418 22.8 Clinical Breast Imaging Techniques 418 22.8.1 Mammography 418 22.8.2 Ultrasonic 420 22.8.3 Magnetic Resonance Imaging 420 22.9 Measurement Systems and Techniques for Microwave Breast Imaging 421 22.9.1 Tomography Using Microwaves 421 22.9.2 Microwave Imaging Using Radar Technology 421 22.9.3 Breast Cancer Detection Using Biosensors 422 22.9.4 Use of Thermography to Find Breast Cancer 422 22.10 Discussion 423 22.11 Present Developments and Prospects for Breast Cancer Screening Methods 423 22.12 Conclusion 426 References 426 23 Future of Neurological Research: Leveraging Artificial Intelligence for Precision and Discovery 431 Hemlata and Utsav Krishan Murari 23.1 Introduction 431 23.2 AI in Neuroimaging: A Revolution in Neurological Research 435 23.3 Computational Neuroscience and Modeling: Transforming Understanding of Neural Mechanisms through AI 438 23.4 AI and BCIs: Transforming Accessibility and Real-Time Neural Interaction 441 23.5 Ethics in the Integration of AI Into Neurological Research 445 23.6 Conclusion 448 References 449 24 Cervical Cancer Detection Using Machine Learning 451 Saranya. A., S. Ravi, Harsha Latha. P., T. Kalaichelvi and A. Anbarasi 24.1 Introduction 452 24.1.1 Overview of Medical Image Analysis 454 24.2 ml Techniques for Cervical Cancer Diagnosis 459 24.2.1 ml Algorithms 459 24.2.2 Methodology of ML Classification of Images 460 24.2.3 Cervical Cancer Image Dataset 462 24.3 Related Work 462 24.3.1 Cervical Cancer Detection Using ml 463 24.4 Findings 466 24.5 Performance Metrics in ml 470 24.6 Conclusion 471 References 472 25 Deep Learning Techniques–Based Medical Image Segmentation in Cervical Cancer 477 Saranya. A., S. Ravi, Harsha Latha. P. and T. Kalaichelvi 25.1 Introduction 478 25.2 Motivation of Computer-Aided Diagnosis 480 25.3 History of DL in Medical Imaging 482 25.4 Deep Learning Application of Cervical Cancer 482 25.5 Cervical Cancer Detection Based on DL Techniques for Medical Image Segmentation 483 25.5.1 Deep Learning in Image Segmentation 483 25.5.2 Deep Learning in Classification Task 487 25.6 Frameworks Used in Detecting Cervical Cancer 488 25.6.1 Comparison Between DL Segmentation and Classification 489 25.7 Performance Metrics 494 25.8 Conclusion 495 References 495 Index 499